Global mRNA Cancer Vaccines and Therapeutics Competitive Landscape Professional Research Report 2024

Global mRNA Cancer Vaccines and Therapeutics Competitive Landscape Professional Research Report 2024



Research Summary

mRNA (messenger RNA) cancer vaccines and therapeutics represent a groundbreaking approach to cancer treatment and prevention. These innovative therapies use synthetic mRNA molecules to instruct the patient's own cells to produce specific proteins or antigens that stimulate the immune system to recognize and target cancer cells. mRNA cancer vaccines can be tailored to an individual's unique cancer profile, making them a promising avenue for personalized cancer treatment. By training the immune system to recognize and attack cancer cells, these vaccines hold the potential to provide effective, targeted, and less invasive treatment options. Additionally, mRNA technology has gained prominence for its role in the development of COVID-19 vaccines, underscoring its versatility and transformative potential in the field of medicine and disease prevention.

According to DIResearch's in-depth investigation and research, the global mRNA Cancer Vaccines and Therapeutics market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of mRNA Cancer Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of mRNA Cancer Vaccines and Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global mRNA Cancer Vaccines and Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the mRNA Cancer Vaccines and Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Cancer Vaccines and Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of mRNA Cancer Vaccines and Therapeutics Include:

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

mRNA Cancer Vaccines and Therapeutics Product Segment Include:

Vaccines

Therapeutics

mRNA Cancer Vaccines and Therapeutics Product Application Include:

Adenocarcinoma

Mucinous Carcinoma

Adenosquamous Carcinoma

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global mRNA Cancer Vaccines and Therapeutics Industry PESTEL Analysis

Chapter 3: Global mRNA Cancer Vaccines and Therapeutics Industry Porter’s Five Forces Analysis

Chapter 4: Global mRNA Cancer Vaccines and Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global mRNA Cancer Vaccines and Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 mRNA Cancer Vaccines and Therapeutics Market Overview
1.1 Product Definition and Statistical Scope
1.2 mRNA Cancer Vaccines and Therapeutics Product by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Vaccines
1.2.3 Therapeutics
1.3 mRNA Cancer Vaccines and Therapeutics Product by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Adenocarcinoma
1.3.3 Mucinous Carcinoma
1.3.4 Adenosquamous Carcinoma
1.3.5 Others
1.4 Global mRNA Cancer Vaccines and Therapeutics Market Revenue Analysis (2019-2030)
1.5 mRNA Cancer Vaccines and Therapeutics Market Development Status and Trends
1.5.1 mRNA Cancer Vaccines and Therapeutics Industry Development Status Analysis
1.5.2 mRNA Cancer Vaccines and Therapeutics Industry Development Trends Analysis
2 mRNA Cancer Vaccines and Therapeutics Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 mRNA Cancer Vaccines and Therapeutics Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global mRNA Cancer Vaccines and Therapeutics Market Analysis by Regions
4.1 mRNA Cancer Vaccines and Therapeutics Overall Market: 2023 VS 2024 VS 2030
4.2 Global mRNA Cancer Vaccines and Therapeutics Revenue and Forecast Analysis (2019-2030)
4.2.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Region (2019-2024)
4.2.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Region (2025-2030)
5 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type and Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type
5.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application
6.5 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
7.5 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China mRNA Cancer Vaccines and Therapeutics Market Size by Type
8.4 China mRNA Cancer Vaccines and Therapeutics Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Type
9.4 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Application
9.5 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type
10.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application
10.5 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
11.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
11.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global mRNA Cancer Vaccines and Therapeutics Market Revenue by Key Manufacturers (2020-2024)
12.2 mRNA Cancer Vaccines and Therapeutics Competitive Landscape Analysis and Market Dynamic
12.2.1 mRNA Cancer Vaccines and Therapeutics Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Moderna Therapeutics
13.1.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 CureVac
13.2.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Translate Bio
13.3.1 Translate Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 BioNTech
13.4.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Sangamo Therapeutics
13.5.1 Sangamo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 Argos Therapeutics
13.6.1 Argos Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 In-Cell-Art
13.7.1 In-Cell-Art Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 eTheRNA
13.8.1 eTheRNA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 Ethris
13.9.1 Ethris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Tiba Biotechnology
13.10.1 Tiba Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Portfolio
13.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis
14.2 mRNA Cancer Vaccines and Therapeutics Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 mRNA Cancer Vaccines and Therapeutics Typical Downstream Customers
14.4 mRNA Cancer Vaccines and Therapeutics Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings